Importance of Mevalonate Pathway Lipids on the Growth and Survival of Primary and Metastatic Gastric Carcinoma Cells
Authors:
Open Access
- 1 May 2021
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Gastroenterology
- Vol. ume 14, 217-228
Abstract
Purpose: This preclinical study aims to determine the effect of drugs that alter isoprenoids and cholesterol metabolism in the homeostasis of gastric carcinoma cell lines in the search for new therapeutic targets for stomach cancer. Materials and Methods: Primary (AGS) and metastatic (NCI-N87) gastric cancer cell lines were treated with simvastatin and terbinafine, two inhibitors of the mevalonate pathway, and avasimibe, an inhibitor of cholesterol esterification. Cell viability and growth were measured as well as cholesterol levels and the expression of the hydroxy methyl-glutaryl CoA reductase (HMGCR) and the LDL receptor (LDLR). Results: Primary and metastatic gastric carcinoma cells show different sensitivity to drugs that affect isoprenoid synthesis and the metabolism and uptake of cholesterol. Isoprenoids are involved in the growth and viability of both types of cells, but the role of free and esterified cholesterol for metastatic gastric cell survival is not as evident as for primary gastric cancer cells. Differential expression of LDLR due to mevalonate pathway inhibition suggests variations in the regulation of cholesterol uptake between primary and metastatic cancer cells. Conclusion: These results indicate that at least for primary gastric cancer, statins and avasimibe are promising candidates as potential novel antitumor drugs that target the metabolism of isoprenoids and cholesterol of gastric tumors.Keywords
This publication has 34 references indexed in Scilit:
- Controlling Cholesterol Synthesis beyond 3-Hydroxy-3-methylglutaryl-CoA Reductase (HMGCR)Journal of Biological Chemistry, 2013
- Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancerBMC Cancer, 2013
- Cholesterol and breast cancer developmentCurrent Opinion in Pharmacology, 2012
- Cholesterol and prostate cancerCurrent Opinion in Pharmacology, 2012
- Targeting tumor cell metabolism with statinsOncogene, 2012
- Cholesterol-Dependent Degradation of Squalene Monooxygenase, a Control Point in Cholesterol Synthesis beyond HMG-CoA ReductaseCell Metabolism, 2011
- Dysregulation of the mevalonate pathway promotes transformationProceedings of the National Academy of Sciences, 2010
- Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cellsJournal of Lipid Research, 2009
- Sulforhodamine B colorimetric assay for cytotoxicity screeningNature Protocols, 2006
- Perspectives on farnesyl transferase inhibitors in cancer therapyCancer Letters, 2004